About Shree Pacetronix
Shree Pacetronix is a company based in Pithampur (India) founded in 1988. The company has 114 employees as of March 31, 2024. Shree Pacetronix operates in a competitive market with competitors including AtaCor Medical, AtriCure, CardioFocus, Kestra Medical Technologies and EBR Systems, among others.
- Headquarter Pithampur, India
- Employees 114 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Shree Pacetronix Limited
-
Annual Revenue
$1.97 M (USD)-23.76as on Mar 31, 2025
-
Net Profit
$87.79 K (USD)-77.67as on Mar 31, 2025
-
EBITDA
$278.7 K (USD)-60.08as on Mar 31, 2025
-
Latest Funding Round
-
Investors
-
Employee Count
114
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Shree Pacetronix
Shree Pacetronix is a publicly listed company on the BSE with ticker symbol SHREEPAC in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Shree Pacetronix
Investments & Acquisitions by Shree Pacetronix
Financial Statements - Shree Pacetronix
Shree Pacetronix Comparisons
Competitors of Shree Pacetronix
Shree Pacetronix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtaCor Medical, AtriCure, CardioFocus, Kestra Medical Technologies and EBR Systems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| domain | founded_year | HQ Location |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| domain | founded_year | HQ Location |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| domain | founded_year | HQ Location |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| domain | founded_year | HQ Location |
Wireless cardiac pacing devices are developed for left ventricle stimulation.
|
|
| domain | founded_year | HQ Location |
Trans-septal implants for atrial fibrillation treatment are developed.
|
Frequently Asked Questions about Shree Pacetronix
Shree Pacetronix was founded in 1988.
Shree Pacetronix is headquartered in Pithampur, India. It is registered at Pithampur, Madhya Pradesh, India.
As of Mar 31, 2024, the latest employee count at Shree Pacetronix is 114.
Annual revenue of Shree Pacetronix is $1.97M as on Mar 31, 2025.
Shree Pacetronix was established in 1988 in Pithampur, India, within the healthcare sector. Focus is placed on producing cardiac pacemakers, including multi-programmable, rate-responsive, and biventricular models, as well as external variants. Pacing leads, such as temporary, introducer, and bipolar types, are also fabricated. Operations include the development of pacing system analyzers to support cardiac device functionality in medical applications.
Shree Pacetronix's top competitors include AtaCor Medical, AtriCure and CardioFocus.
Yes, Shree Pacetronix is publicly traded on BSE under the ticker symbol SHREEPAC.
The ticker symbol of Shree Pacetronix is SHREEPAC on BSE.